Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 1 - 10 of about 161   

Articles published

AZN 4,608.59 +8.09 (0.18%)
price chart
AstraZeneca sells commercial rights to Zoladex cancer treatment
... us to retain a significant share of the value of Zoladex in the US and Canada, while concentrating our resources on our innovative new oncology medicines,” said Mark Mallon, executive vice president of global product and portfolio strategy at ...
AstraZeneca plc: AstraZeneca enters agreement with TerSera Therapeutics for ...  The Wall Street Transcript
TOP NEWS: AstraZeneca Signs Deal For Zoladex Rights In North America  London South East (registration) (blog)
AstraZeneca reveals positive breast cancer treatment trial results; Woodford ...
Drugs giant AstraZeneca PLC (LON:AZN) today revealed positive results from phase 3 trials of a breast cancer treatment, while its top shareholder Woodford Investment Management has reportedly raised its holdings in the blue chip firm.
AstraZeneca's Lynparza meets main goal in breast cancer study  Reuters UK
Market Risers: AstraZeneca plc, BAE Systems plc, BT Group plc, Carnival plc
The trading price for AstraZeneca plc ticker lookup code: LON:AZN has gained 1.05% or 48 points during today's session so far.
Analyst Activity – Beaufort Securities Reiterates Hold on AstraZeneca plc ...  Market Exclusive
AstraZeneca plc (AZN) Given a GBX 3900 Price Target by Goldman Sachs Group ...  BNB Daily (blog)
AstraZeneca plc 19.5% Potential Upside Indicated by Berenberg
AstraZeneca plc using EPIC/TICKER code LON:AZN has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Berenberg.
Analyst Activity – Berenberg Bank Reiterates Buy on Astrazeneca PLC (NYSE:AZN)  Market Exclusive
Forward Earnings Estimate of Astrazeneca PLC(AZN)  Highland Mirror
Astrazeneca PLC (AZN) Ex-Dividend Date Scheduled for February 15, 2017
Astrazeneca PLC ( AZN ) will begin trading ex-dividend on February 15, 2017. A cash dividend payment of $0.93 per share is scheduled to be paid on March 20, 2017.
AstraZeneca PLC (NYSE:AZN) Fell -0.17%  TopChronicle
5 Dividend Stocks Yielding More Than 4%: BT Group plc, AstraZeneca plc ...  Investomania (blog)
AstraZeneca Plc (AZN) Q4 2016 Results - Earnings Call Transcript
Okay. Hello, everyone. I'm Pascal Soriot, CEO of AstraZeneca. Welcome to this Full-Year and Fourth Quarter 2016 Results Presentation for our Investors and Analysts.
AstraZeneca plc 13.6% Potential Upside Indicated by Jefferies International  DirectorsTalk Interviews
AstraZeneca plc (ADR) (AZN) Releases Earnings Results, Beats Expectations By ...  Highland Mirror
AstraZeneca: Never mind the sales, look at the dividend yield
AstraZeneca PLC (LON:AZN) has waved goodbye to the last of its blockbusters - a landmark reflected in the financial performance of the drugs giant in the fourth quarter.
Should you buy or sell AstraZeneca plc after FY sales fall 5%?  Motley Fool UK
AstraZeneca plc: Full-Year and Q4 2016 Results  The Wall Street Transcript
PRIMECAP Management Buys AstraZeneca PLC, Alkermes PLC, Whirlpool, Sells Union ...
PRIMECAP Management added to the holdings in AstraZeneca PLC by 50.06%. The purchase prices were between $25.81 and $33, with an estimated average price of $28.39.
Beacon Trust Co Buys TD Ameritrade Holding, Intuit, Fortive, Sells Mondelez ...
Market Risers: AstraZeneca plc, Barclays PLC, BP plc, GlaxoSmithKline plc
Shares of AstraZeneca plc company symbol: LON:AZN has stepped up 1.43% or 64 points throughout today's trading session so far.
Shares of Astrazeneca PLC (AZN) Sees Large Outflow of Money  Highland Mirror
Stock's Buzzers: AstraZeneca PLC (NYSE:AZN)  TopChronicle
China MediTech And AstraZeneca Plc (NYSE: AZN) To Present Savolitinib Phase II ...
Hutchison China MediTech Limited and AstraZeneca Plc (NYSE: AZN) are to present data from their phase II clinical trials of Savolitinib, at the upcoming 2017 Genitourinary Cancers Symposium.